Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ·Healthcare·Biotechnology
$70.17
-4.67%
Mkt Cap $10.35B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $213.94M | $264.03M | +23.41% | $0.60 | $0.22 | -63.33% | — | — |
| Q4 2025 Nov 25, 2025 | $175.32M | $256.47M | +46.29% | -$0.11 | -$0.18 | -61.33% | — | — |
| Q3 2025 Aug 7, 2025 | $154.06M | $27.77M | -81.98% | -$0.94 | -$1.26 | -34.04% | — | — |
| Q2 2025 May 12, 2025 | $116.27M | $542.71M | +366.77% | -$0.06 | $2.75 | +4683.33% | — | — |
| Q1 2025 Feb 10, 2025 | $19.05M | $2.50M | -86.88% | -$0.42 | -$1.39 | -230.95% | — | — |
| Q4 2024 Nov 26, 2024 | $55.07M | $3.55M | -93.55% | -$1.05 | -$1.38 | -31.43% | — | — |
| Q3 2024 Aug 8, 2024 | $69.67M | — | — | -$0.58 | -$1.38 | -137.93% | — | — |
| Q2 2024 May 9, 2024 | $63.87M | — | — | -$0.06 | -$1.02 | -1600.00% | — | — |
| Q1 2024 Feb 6, 2024 | $29.51M | $3.55M | -87.97% | -$0.78 | -$1.24 | -58.97% | — | — |
| Q4 2023 Nov 29, 2023 | $50.73M | $16.10M | -68.27% | -$0.70 | -$1.03 | -47.14% | — | — |
| Q3 2023 Aug 7, 2023 | $59.82M | $15.82M | -73.55% | -$0.58 | -$0.96 | -65.52% | — | — |
| Q2 2023 May 2, 2023 | $45.48M | $146.27M | +221.61% | -$0.64 | $0.45 | +170.31% | — | — |
| Q1 2023 Feb 6, 2023 | $162.52M | $62.55M | -61.51% | $1.14 | -$0.39 | -134.21% | — | — |
| Q4 2022 Nov 28, 2022 | $50.30M | $31.57M | -37.22% | -$0.57 | -$0.81 | -42.11% | — | — |
| Q3 2022 Aug 4, 2022 | $45.75M | $32.41M | -29.16% | -$0.45 | -$0.68 | -51.11% | — | — |
| Q2 2022 May 10, 2022 | $122.15M | $151.81M | +24.28% | -$0.08 | $0.41 | +612.50% | — | — |
| Q1 2022 Feb 2, 2022 | $47.81M | $27.44M | -42.61% | -$0.22 | -$0.60 | -172.73% | — | — |
| Q4 2021 Nov 22, 2021 | $37.23M | $38.28M | +2.83% | -$0.11 | -$0.61 | -478.47% | — | — |
| Q3 2021 Aug 5, 2021 | $37.52M | $45.89M | +22.31% | -$0.08 | -$0.29 | -262.50% | — | — |
| Q2 2021 May 4, 2021 | $37.70M | $32.81M | -12.97% | -$0.09 | -$0.26 | -188.89% | — | — |